Glenmede Trust Company »

Urogen Pharma shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $189k 11k 17.98

More positions owned by Glenmede Trust Company

Vanguard Index Fds S&p 500 Etf S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares S & P Smallcap 600 Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Call On Spy 12/18/26 @ 680 Tr Unit Call Option (SPY)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Ishares Russell 2500 Etf Rusel 2500 Etf (SMMD)
Putnam Focused Large Cap Value Etf Focused Lar Cap (PVAL)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Small Cap Etf Small Cp Etf (VB)

View all positions for Glenmede Trust Company

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Toronto-Dominion Bank
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
Paradigm Biocapital Advisors
Acorn Capital Advisors
SG Americas Securities
American Century Companies
Silverarc Capital Management
Opaleye Management
Frontier Capital Management
Menora Mivtachim Holdings
D. E. Shaw & Co

View all funds holding Urogen Pharma